Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

Certain short peptides can increase root hair growth in tobacco plants.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

AH-001 could be a safer and more effective treatment for hair loss.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The peach gene pCTG134 helps control the interaction between auxin and ethylene hormones during fruit ripening.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Progesterone reduces spinal reflex activity by increasing certain GABA(A) receptor subtypes.

OXTR agonists may promote hair growth and be effective for treating hair loss.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The peach gene CTG134 helps control the interaction between auxin and ethylene, which could lead to new agricultural chemicals.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A new compound may treat benign prostatic hyperplasia better than finasteride.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.